Rectifypharma
Founded 2020 · 22 employees on LinkedIn · 4 known investors
Find your way into Rectifypharma
Sign up to see every warm intro you have to Rectifypharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rectifypharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rectify Pharma is a biotechnology company developing therapies, with a pipeline that has included work in liver and metabolic disease areas. This page profiles a member of its executive team.
Founders & leadership
Investors · 4
How we know: Atlas Venture's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: DC Investment Partners's portfolio page · Not right? Tell us
How we know: Longwood Fund's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Founder mafia
3 people who came through Rectifypharma went on to found or lead other companies.
Frequently asked questions
- What does Rectifypharma do?
- Rectify Pharma is a biotechnology company developing therapies, with a pipeline that has included work in liver and metabolic disease areas. This page profiles a member of its executive team.
- Who are Rectifypharma's investors?
- Rectifypharma's investors include Atlas Venture, DC Investment Partners, Longwood Fund, Forbion.






